Turning Point Brands Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
3.7%projected annual EPS growth
Analyst Coverage
6analysts covering
FY Revenue (est.)
$564.3Mnext fiscal year
FY EPS (est.)
$1.88next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 4 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Modern Oral Net Sales Quarterly52MTarget: 210000000 to 225000000
Consolidated Net Sales Quarterly124.3M
Stoker's Segment Net Sales Quarterly87.6M
Zig-Zag Segment Net Sales Quarterly36.7M
Watch Items
- Zig-Zag Segment Revenue DeclineTrigger: Further year-over-year declines exceeding 20%Action: Evaluate product mix, pricing strategies, and the impact of the Clipper distribution unwind.
- Modern Oral Margin Expansion and OnshoringTrigger: Delays in transitioning production to the Louisville facilityAction: Assess impact on the 70% long-term margin target and adjust marketing spend accordingly.
- PMTA Regulatory ApprovalsTrigger: FDA marketing denial orders (MDOs) for key pouch productsAction: Reallocate capital to authorized product lines and review legal appeal options.
Research as of 20 Jun 2026